Amsterdam, the Netherlands and Cambridge, MA – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced that the Center for Devices and Radiological Health (CDRH) of ...
Amsterdam, the Netherlands –Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced that the Center for Devices and Radiological Health (CDRH) of the Food and Drug ...
Hundreds of thousands of automated external defibrillators (AEDs) made by Philips Healthcare might not deliver a needed shock to the heart in an emergency, the U.S. Food and Drug Administration said ...
SILVER SPRING, Md. — The Food and Drug Administration on Tuesday issued a safety communication on HeartStart automated external defibrillators from Philips Healthcare, noting that certain HeartStart ...
Clever design, close attention to human safety issues, and a top man-machine interface make the Philips HeartStart portable home defibrillator one of the hottest medical electronics devices on the ...
Royal Philips Electronics, a Dutch company whose U.S. medical device operations are in Andover, has won clearance from the U.S. Food and Drug Administration (FDA) for the HeartStart Home Defibrillator ...
Sept. 23, 2004 -- The U.S. Food and Drug Administration (FDA) has approved a home defibrillator for sale without a prescription; a C-reactive protein assay to determine the risk of coronary heart ...
Philips recalled its HeartStart MRx Defibrillator due to an equipment defect, according to a Feb. 9 safety notice from the FDA. Here are three things to know. 1. Philips initiated the recall in June ...
Certain HeartStart automated external defibrillator devices made by Philips Medical Systems might be unable to deliver needed defibrillator shocks in a cardiac emergency, the Food and Drug ...
People will soon be able to plunk down $2,295 for an at-home defibrillator in hopes their loved ones will pull it out and save them if their hearts suddenly stop beating. The Food and Drug ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果